Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950131-97-001024
Filing Date
1997-02-14
Accepted
1997-02-14 00:00:00
Documents
1
Group Members
DAVERMAN JAMES EJED LIMITED PARTNERSHIPLDR LIMITED PARTNERSHIPLLOYD D RUTHMARQUETTE GENERAL II LPMARQUETTE VENTURE PARTNER II LPMVP II AFFILIATES FUND LP
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 33992
  Complete submission text file 0000950131-97-001024.txt   36027
Mailing Address 301 SOUTH STATE ST NEWTON PA 18940
Business Address 301 SOUTH STATE ST NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47825 | Film No.: 97533888
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 500 CORPORATE CENTRE 520 LAKE COOK ROAD SUITE 450 DEERFIELD IL 60015 8474058396
DAVERMAN JAMES E (Filed by) CIK: 0001033489 (see all company filings)